HCG on TRT: what the evidence says about low-dose use

What did @alphaclubsupps actually say?

The creator argues that HCG on TRT is widely misunderstood, with men either skipping it entirely or using too much. His core recommendation: "250 IU, 2 to 3 times a week should be fine" to maintain testicular function and fertility. He also warns that excess HCG drives estrogen up, which leads men into a cycle of adding aromatase inhibitors and accumulating compounds.

The framing is practical and the tone is measured. He's not pushing a stack or selling a protocol upgrade. He's telling guys to start low, wait a couple of months, then titrate up by 250 IU increments if needed. That's a more restrained approach than you typically see from supplement-adjacent TikTok accounts. Credit where it's due.

Does the science back this up?

Mostly, yes. The evidence on low-dose HCG for testicular maintenance during TRT is reasonably solid, though it's not as clean as the video implies.

HCG acts as a luteinizing hormone (LH) analogue, binding to LH receptors in Leydig cells to stimulate intratesticular testosterone production. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, which shuts down endogenous LH and causes testicular atrophy and impaired spermatogenesis. HCG partially offsets this. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that low-dose HCG, at 125-500 IU every other day, maintained intratesticular testosterone levels in testosterone-treated men. The 250 IU dosing range the creator cites sits within what the literature has examined.

The estrogen concern is also real. HCG stimulates aromatase activity in Leydig cells, not just testosterone synthesis, so higher doses predictably increase estradiol. Ramasamy et al. (2014, BJU International) noted elevated estrogen as a dose-dependent side effect in men using HCG for fertility preservation during TRT.

What did they get wrong (or right)?

The creator gets the mechanism right: HCG mimics LH, and that matters for anyone on TRT who wants to preserve fertility or avoid significant testicular atrophy. The estrogen-escalation warning is accurate and genuinely useful. The cascading-compounds problem he describes is real clinical territory.

Where it gets shakier: he presents 250 IU two to three times per week as a general starting dose without any context about individual variability. That's a reasonable population-level estimate, but some men respond at lower doses and some need more. There's no single correct dose. The Coviello study used every-other-day dosing, not a twice-weekly schedule, and the pharmacokinetics of HCG mean timing and frequency matter more than many creators acknowledge.

Also worth noting: the creator is running a supplement brand account. He doesn't explicitly recommend a physician or bloodwork at any point. Starting any hormonal adjunct without baseline and follow-up labs is a problem regardless of how low the dose is.

What should you actually know?

HCG is not a supplement. It's a prescription medication in most countries, including the UK and US, and it requires a licensed prescriber. Dosing decisions should be driven by lab values, specifically LH, FSH, estradiol, and semen analysis if fertility is a concern, not by a starting-point heuristic from a social media video.

The clinical literature does support low-dose HCG co-administration with TRT for men who want to preserve fertility or testicular volume. A 2013 review by Lipshultz et al. in Fertility and Sterility confirmed HCG can maintain spermatogenesis in hypogonadal men on testosterone therapy. But the same literature makes clear that protocols need to be individualised and monitored.

If you're on TRT and considering HCG, the conversation starts with your prescriber and a hormone panel, not a TikTok comment section. The creator's instinct to "keep it simple" is reasonable. The delivery channel is not.